Advisory Excellence
  • Home
  • Find an Advisor
  • Annual Awards
    • Nominations
    • Annual 2025 Awards
    • Previous Winners
  • News
  • Apply
  • About
    • Services
  • Contact
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
  • Link to LinkedIn
  • Link to Pinterest
  • Link to Youtube
  • Link to Instagram
  • Link to X
  • Link to Facebook
  • Link to Reddit
  • Link to Soundcloud
  • Link to Vk

Archive for category: Pharma

Why Inventory Control in Pharmacy Management Drives Profitability

June 24, 2026/in Pharma/by Advisory Excellence

Pharmacy profit is shaped long before a prescription reaches the counter. It begins with purchasing discipline, accurate counts, expiration awareness, and clear visibility into demand. Each package on a shelf represents cash, clinical responsibility, and patient access. When stock decisions align with actual dispensing patterns, pharmacies protect margins without compromising care. Rising drug costs make this discipline essential for steady earnings.

Stock Data Sets the Pace

Accurate stock records help teams connect ordering with refill cycles, seasonal use, prescriber trends, and payer behavior. Strong inventory control in the pharmacy reduces excess supply and lowers the risk of missed fills. That balance preserves cash, prevents avoidable waste, and keeps patients receiving therapy on schedule.

Cash Flow Starts on the Shelf

Inventory is usually one of a pharmacy’s largest financial assets. Excess product ties up funds needed for payroll, equipment, taxes, or supplier payments. Thin supply can cost sales and weaken patient loyalty. Better purchasing is guided by dispensing history, refill timing, reimbursement pressure, and wholesaler terms. Shelf control becomes cash control when every order has a clear reason.

Expired Drugs Cut Margins

Expired medication creates an immediate loss because the paid product can no longer be dispensed. Short-dated stock also raises safety concerns if checks are irregular. Cycle counts, shelf reviews, and return tracking help protect value before dates pass. Aging reports give managers a practical way to move, return, or reduce items before the margin disappears.

Generics Need Careful Balance

Generic medications often carry healthier margins, but they still require disciplined buying. Slow movers can sit too long, while common therapies must remain available. Reorder points should reflect current demand rather than staff habit. By reviewing volume, seasonality, and reimbursement, pharmacy leaders can keep essential generics available without overloading shelves.

Brand Demand Can Shift Fast

Brand-name medicines can carry high acquisition costs. One unnecessary order may lock substantial cash into a single product. Demand for diabetes care, weight management, vaccines, and chronic therapy can shift with local prescribing patterns. Pharmacies reduce financial strain by watching claims, refill gaps, and physician activity. Lean buying works best when visibility is up to date.

Patient Care Protects Revenue

Patients rely on pharmacies for timely access to prescribed medications. A stockout can interrupt treatment and send a patient elsewhere. Reliable availability supports adherence, refill retention, and trust between staff and families. It also saves labor that would otherwise be spent on supplier calls, apologies, and transfers. Better service often shows up later as steadier revenue.

Synchronization Improves Forecasting

Medication synchronization gives teams a clearer view of upcoming demand. Timely refills make ordering less reactive and reduce last-minute purchases. Patients benefit from fewer trips and more consistent therapy routines. Staff can plan workload, supplier orders, and cash needs with greater accuracy. Predictable timing helps both clinical service and margin control.

Vaccines Require Early Planning

Vaccines need to be stocked, with seasonal demand and storage requirements in mind. Too few doses limit revenue during peak demand. Too many increase waste after community interest declines. Prior-year activity, local illness patterns, and appointment volume should guide preorders. Early planning also supports staffing, refrigeration capacity, and patient outreach before the respiratory season reaches its busiest weeks.

Compliance Also Affects Profit

Inventory records support audit readiness, controlled-substance oversight, and supply-chain requirements. Weak documentation can lead to chargebacks, penalties, or lost reimbursement. Accurate receiving, dispensing, and return records protect both patients and the business. Monthly checks for outdated medication, count discrepancies, and supplier credits reduce financial exposure while maintaining more reliable operations.

Reports Turn Data Into Action

Reports should show what moves, what stalls, and where purchasing needs adjustment. Refill summaries, movement reports, gross margin views, and return data reveal patterns that daily observation can miss. Managers can refine reorder points, reduce surplus, and improve buying schedules. Data matters most when leaders review it regularly and act quickly.

Staff Habits Matter Daily

Software helps, but consistent staff behavior keeps records useful. Teams need clear steps for receiving, shelving, counting, and flagging aging items. Small errors can grow into ordering problems or audit risk. Managers should assign ownership for costly medications, seasonal products, and controlled substances. Accountability turns stock management into a daily financial safeguard.

Conclusion

Pharmacy profitability depends on more than prescription volume. It rests on how carefully each product is purchased, stored, tracked, and moved before value is lost. Strong inventory practices reduce waste, protect cash flow, support patient access, and improve decisions at every counter. Pharmacies that treat stock as a financial and clinical control build healthier margins and more dependable care.

The Sackler Family, Purdue Pharma, and the Opioid Crisis: Unveiling the Pain Management Business

August 7, 2021/in Pharma/by News Desk

The Sackler Family, Purdue Pharma, and the opioid crisis have become synonymous with one of the most devastating public health emergencies in recent history. This article sheds light on the intricate web of events that led to the opioid epidemic, highlighting the role of Purdue Pharma and the Sackler Family in shaping the pain management business. By examining the origins, marketing tactics, legal battles, and repercussions of the crisis, we aim to provide a comprehensive and informative overview of this deeply troubling issue.

Origins of the Opioid Crisis

The opioid crisis traces its roots back to the late 1990s when prescription opioids were aggressively marketed as a panacea for pain relief. Purdue Pharma, a pharmaceutical company founded by the Sackler Family, played a pivotal role in the promotion of these potent painkillers. OxyContin, a time-release opioid developed by Purdue Pharma, was marketed as a breakthrough solution for chronic pain. However, the aggressive marketing campaign obscured the risks of addiction and downplayed the potential for abuse.

Marketing Tactics and Controversies

Purdue Pharma’s marketing tactics were instrumental in driving the opioid crisis. The company employed an aggressive promotional strategy that included incentivising doctors to prescribe OxyContin, downplaying addiction risks, and targeting vulnerable populations. Purdue Pharma’s representatives often used misleading and unverified claims, asserting that OxyContin had a low potential for addiction, which contributed to its widespread prescription.

The Sackler Family’s Role

The Sackler Family, owners of Purdue Pharma, amassed a substantial fortune through their involvement in the pharmaceutical industry. However, their legacy is marred by allegations that they prioritised profits over public health. The Sacklers’ influence extended beyond Purdue Pharma, as they also made substantial donations to cultural and educational institutions. These philanthropic endeavours, while laudable on the surface, have faced criticism for potentially whitewashing their involvement in the opioid crisis.

Legal Battles and Accountability

As the opioid crisis escalated, Purdue Pharma faced legal challenges from various quarters. The company was accused of misleading marketing practices and downplaying the addictive nature of opioids. In 2019, Purdue Pharma filed for bankruptcy in the face of numerous lawsuits, leading to a proposed settlement that aimed to provide compensation to affected communities. However, many critics argue that the settlement did not go far enough in holding the company and the Sackler Family accountable for their actions.

Repercussions and Public Health Impact

The opioid crisis has had a devastating impact on public health, resulting in a surge of opioid-related overdose deaths and an increase in addiction rates. The crisis has strained healthcare systems, law enforcement, and social services across the United States and beyond. Efforts to address the crisis have led to increased awareness about the dangers of prescription opioids, stricter regulations on opioid prescriptions, and expanded access to addiction treatment programs.

Conclusion

The Sackler Family, Purdue Pharma, and the opioid crisis have left an indelible mark on society, underscoring the complex interplay between pharmaceutical companies, public health, and corporate responsibility. The aggressive marketing and promotion of opioids, coupled with a lack of accountability, have contributed to an unprecedented public health emergency. While efforts are underway to address the opioid crisis and provide support to affected communities, the lessons learned from this tragic chapter serve as a stark reminder of the importance of ethical pharmaceutical practices and the need to prioritise public health over profit.

Latest News

  • How Church Facility Use Can Affect Insurance Coverage in Texas
  • What are the Top Positions Companies Hire Through EOR
  • Understanding the Role of Injury Law After a Car Accident
  • How Air Duct Services Improve Airflow and Indoor Air Quality Fast
  • What a Septic System Warranty Covers That Standard Plans Miss

Categories

Quick Links

  • Home
  • About
  • Expertise
  • Countries
  • News
  • Contact

About Advisory Excellence

Advisory Excellence profiles the best advisers around the globe, enabling users to quickly and easily find the expert they need in their location. All applicants are subjected to a stringent vetting process prior to acceptance.

Join Advisory Excellence

If you would like to apply for membership, simply fill out your details on our application form. If you have not heard back from us within 2 weeks of submitting the application, we are afraid that means your application has not been successful.

News Feed

  • How Church Facility Use Can Affect Insurance Coverage in Texas
  • What are the Top Positions Companies Hire Through EOR
  • Understanding the Role of Injury Law After a Car Accident
© Advisory Excellence.
  • Link to LinkedIn
  • Link to Pinterest
  • Link to Youtube
  • Link to Instagram
  • Link to X
  • Link to Facebook
  • Link to Reddit
  • Link to Soundcloud
  • Link to Vk
Scroll to top Scroll to top Scroll to top